Motor neuron survival pathways

Motor neuron survival pathways" is not a single molecular target, receptor, or protein, but rather a general term describing a collection of intracellular signaling cascades and molecular factors that govern the survival, maintenance, and death of motor neurons. These pathways involve multiple molecular mechanisms and diverse molecules, such as neurotrophic factors (e.g., brain-derived neurotrophic factor, ciliary neurotrophic factor, glial cell line-derived neurotrophic factor), kinases (e.g., MAP4Ks, Rho-kinase), anti- and pro-apoptotic proteins (e.g., BCL-2 family, caspases), and proteins required for neuronal maintenance (e.g., survival motor neuron (SMN) protein)[1][2][3][4][5][6][7]. The term as stated is too broad and does not conform to a specific, actionable therapeutic target or receptor suitable for drug discovery or structured annotation. **Supporting details:** - The phrase encompasses a network of factors and does not refer to a single molecule, gene, or protein. - Multiple signaling molecules and pathways (such as neurotrophic factors like BDNF, CNTF, GDNF, VEGF; kinases like Rho-kinase and MAP4Ks; apoptotic regulators like BCL-2, BAX, and caspases) are implicated in regulating motor neuron survival and their dysfunction in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS)[2][3][4][6][7]. - Some individual components of these pathways *are* recognized as therapeutic targets (e.g., MAP4K family kinases[4] or SMN protein in spinal muscular atrophy[5]), but "motor neuron survival pathways" as a collective term is not. - Therefore, this entry is not suitable for a structured target annotation as defined by your conventions.